Goldman Sachs’s CNOVA N.V. CNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-299,935
Closed -$1.64M 7217
2016
Q4
$1.64M Buy
299,935
+12,708
+4% +$69.1K ﹤0.01% 4030
2016
Q3
$1.54M Buy
287,227
+257,897
+879% +$1.33M ﹤0.01% 4035
2016
Q2
$145K Buy
29,330
+1,457
+5% +$6.18K ﹤0.01% 5916
2016
Q1
$84K Buy
+27,873
New +$66.9K ﹤0.01% 6162
2015
Q4
Sell
-15,423
Closed -$47K 7544
2015
Q3
$47K Sell
15,423
-4,391
-22% -$20.5K ﹤0.01% 6819
2015
Q2
$110K Sell
19,814
-3,682
-16% -$22K ﹤0.01% 6562
2015
Q1
$148K Buy
23,496
+5,839
+33% +$38.4K ﹤0.01% 6220
2014
Q4
$140K Buy
+17,657
New +$127K ﹤0.01% 6405

Other funds holding CNV

Goldman Sachs's CNV Position: Q1 2017 in Review

Goldman Sachs sold out of CNOVA N.V. (CNV) in Q1 2017, closing a stake of 299,935 shares — an estimated $1.64M sold.

Goldman Sachs first reported a position in CNV in Q4 2014 and held it in 8 quarters. The position peaked at $1.64M in Q4 2016. 2 funds tracked by Wall St. Rank hold CNV as of Q1 2017.

  • Goldman Sachs reported no remaining CNOVA N.V. position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 299,935 CNOVA N.V. shares in Q1 2017, an estimated $1.64M.
  • Goldman Sachs first reported a position in CNOVA N.V. in Q4 2014 and held it in 8 quarters.
  • Goldman Sachs's CNOVA N.V. position peaked at $1.64M in Q4 2016.
  • 2 funds tracked by Wall St. Rank held CNOVA N.V. as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.